{"id":"W2752446656","doi":"10.3310/hta21490","title":"Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness","year":2017,"lang":"en","type":"article","venue":"Health Technology Assessment","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"NOSM University","funders":"Health Technology Assessment Programme; National Institutes of Health; H. Lundbeck A/S; University of Sheffield; Otsuka Pharmaceutical; Cilag; University of Manchester; Sunovion; University of Southampton; National Institute for Health and Care Research; Amicus Therapeutics; Eli Lilly and Company","keywords":"Amisulpride; Clozapine; Medicine; Placebo; Antipsychotic; Schizophrenia (object-oriented programming); Randomized controlled trial; Atypical antipsychotic; Positive and Negative Syndrome Scale; Odds ratio; Psychiatry; Internal medicine; Psychosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005208958,0.00213865,0.00413949,0.001372794,0.0006531772,0.001611973,0.001025817,0.00406422,0.008896058],"category_scores_gemma":[0.007246747,0.001211162,0.003607241,0.0009171815,0.002036226,0.001406485,0.0009338034,0.002233989,0.0007179172],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001548,"about_ca_system_score_gemma":0.002014959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00228649,"about_ca_topic_score_gemma":0.002788678,"domain_scores_codex":[0.9958571,0.002868514,0.0003857146,0.0003568644,0.0002491736,0.0002827093],"domain_scores_gemma":[0.9964798,0.001525679,0.0009597213,0.0001931183,0.0002176275,0.0006241379],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9916399,0.001824372,0.0001412025,0.0008921868,0.0006772163,0.00001554655,0.00002448206,0.0001077567,0.000439939,0.00006539154,0.0001120137,0.004059982],"study_design_scores_gemma":[0.9815381,0.01741179,0.0002615403,0.00004843378,0.0003817302,0.000007666934,0.000009031522,0.0001077045,0.00006823344,0.00005648104,0.0001022313,0.000007189872],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9594679,0.01371167,0.0009908157,0.001277099,0.001483505,0.01905013,0.001036938,0.0001687058,0.002813183],"genre_scores_gemma":[0.971962,0.005778403,0.002716868,0.0008413967,0.001017478,0.0150038,0.0004772013,0.00001895762,0.002183879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008896058,"threshold_uncertainty_score":0.02976024,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.101375323326093,"score_gpt":0.5039599870569764,"score_spread":0.4025846637308834,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}